Comparison of the Uptakes of in Cancer Cell Lines Expressing Multidrug Resistance |
Yoo, Jeong-Ah
(Department of Nuclear Medicine, Kyunkpook National University School of Medicine)
Chung, Shin-Young (Department of Nuclear Medicine, Kyunkpook National University School of Medicine) Seo, Myeng-Rang (Department of Nuclear Medicine, Kyunkpook National University School of Medicine) Kwak, Dong-Suk (Department of Nuclear Medicine, Kyunkpook National University School of Medicine) Ahn, Byeong-Cheol (Department of Nuclear Medicine, Kyunkpook National University School of Medicine) Lee, Kyu-Bo (Department of Nuclear Medicine, Kyunkpook National University School of Medicine) Lee, Jae-Tae (Department of Nuclear Medicine, Kyunkpook National University School of Medicine) |
1 | Balliner JR, Hua BW, Berry BW, Firby P, Boxen I. -sestamibi as an agent for imaging P-glycoproteinmediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant. Nucl Med Commun 1995;16:253-7 |
2 | Kelly JD, Forster AM, Higley B, Archer CM, Booker FS, Canning LR, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993;34:222-7 |
3 | Rao VV, Chiu ML, Kronauge JF, Piwnica-Worms D. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med 1994;35:510-5 |
4 | Rodrigues M, Kalinowska W, Zielinski C, Sinzinger H. Verapamil decreases accumulation of _MIBI and -tetrofosmin in human breast cancer and soft tissue sarcoma cell lines. Nucl Med Commun 2001;22:645-50 |
5 | Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993;53:977-84 |
6 | Breuninger LM, Paul S, Gaughan K, Miki T, Chan A, Aaronson SA. Expression of multidrug resistance associated protein with increased drug efflux and altered intracellular drug distribution. Cancer Res 1995;55: 5342-7 |
7 | Cordobes MD, Starzec A, Delmon-Moingeon L, Blanchot C, Kouyoumdjian Je, Prevost G, et al. Technetium-99m-sestamibi uptake by human benign and malignant breast tumor cells: correlation with mdr gene expression. J Nucl Med 1996;37:286-9 |
8 | Kao CH, Ho YJ, Shen YY, Lee JK. Evaluation of chemotherapy response in patients with small cell lung cancer using technetium-99m-tetrofosmin. Anticancer Res 1999;19:2311-5 |
9 | Rodrigues M, Chehne F, Kalinowska W, Berghammer P, Zielinki C, Sinzinger H. Uptake of 99mTc-MIBI and 99mTc-tetrofosmin into malignant versus nonmalignant breast cell line. J Nucl Med 2000;41:1495-9 |
10 | Taki J, Sumiya H, Asada N, Veda Y, Tsuchiya H, Tonami N. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy. J Nucl Med 1998;39: 1179-84 |
11 | Piwnica-Worms D, Holman BL. Noncardiac applications of hexakis (alkylisonitrile) technetium-99m complexes. J Nucl Med 1990;31:1166-7 |
12 | Choi SU, Kim NY, Choi EJ, Kim KH, Lee CO. Establishment of doxorubicin-resistant subline derived from Hen5 human colorectal cancer cells. Arch Pharm Res 1996;19:342-7 |
13 | Perek N, Prevot N, Koumanov F, Frere D, Sabido O, Beauchesne P, et al. Involvement of the glutathione S-conjugate compounds and the MRP protein in Tc-99m-tetrofosmin and Tc-99m-sestamibi uptake in glioma cell lines. Nucl Med Biol 2000;27:299-307 |
14 | Piwnica-Worms D, Rao VV, Krounage JF, Croop JM Characterization of multidrug resistance transport function with an organotechnetium cation. Biochemistry 1995;34:12210-20 |
15 | Cayre A, Moins N, Finat-Duclos F, Verrelle P, Maublant J. Comparison between technetium-99m-sestamibi and H-3-daunomycin myocardial cellular retention in vitro. J Nucl Med 1997;38:1674-7 |
16 | Meghdsdi S, Karanikas G, Schlabauer-Wadl H, Jansen B, Chehne F, Rodrigues M, et al. Technetium-99m-tetrofosmin: a new agent for melanoma imaging? Anticancer Res 1998;18:2759-62 |
17 | Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-20l in tumor cell lines. J Nucl Med 1996;37: 1551-6 |
18 | Soman P, Taillefer R, DePuey EG, Udelson JE, Lajiri A. Enhanced detection of reversible perfusion defects by 99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease. J Am Coll Cardiol 2001;37: 458-62 |
19 | Lee J. Functional imaging of the multidrug resistance in vivo. Korean J Nucl Med 2001;35:66p-75p |
20 | Ding HJ, Shiau YC, Tsai SC, Wang JJ, Ho ST, Kao A. Uptake of 99mTc tetrofosmin in lymphoma cell lines: a comparative study with 99mTc sestamibi. Appl Radiat Isot. 2002;56:853-6 |
21 | Utsunomiya K, Ballinger JR, Piquette-Miller M, Rauth AM, Tang W, Su ZF, et al. Comparison of the accumulation and efflux kinetics of technetium-99m seestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line. Eur J Nucl Med 2000;27: 1786-92 |
22 | Arbab AS, Koizumi K, Toyama K, Arai T, Araki T. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-20l uptake in rat myocardial cells. J Nucl Med 1998;39:266-71 |
23 | Shen DW, Fojo A, Chin JE, Roninson IB, Richert N, Pastan I. Human multidrug-resistant cell lines: Increased mdr1 expression can precede gene amplification. Science 1986;232:643-5 |
24 | Rodrigues M, Chehne F, Kalinowaka W, Zielinski C, Sinzinger H. Comparative -MIBI, -tetrofosmin and -furifosmin uptake in human soft tissue sarcoma cell lines. Eur J Nucl Med 2000;27:1839-43 |
25 | Chun KA, Lee J, Lee SW, Kang DY, Sohn SK, Lee JK, et al. Effect of multidrug resistance gene-l (mdrl) overexpression on in-vitro uptake of -sestamibi in murine L1210 leukemia cells. Korean J Nucl Med 1999;33:152-62 |
26 | Kostakoglu L, Elahi N, Kiratli P, Ruacan S, Sayek I, Baltali E. Clinical validation of the influence of P-glycoprotein on technetium-99m-sestamibi uptake in malignant tumors. J Nucl Med 1997;38:1003-8 |